Muscaritoli Maurizio, Krznarić Zeljko, Singer Pierre, Barazzoni Rocco, Cederholm Tommy, Golay Alain, Van Gossum André, Kennedy Nicholas, Kreymann Georg, Laviano Alessandro, Pavić Tajana, Puljak Livia, Sambunjak Dario, Utrobičić Ana, Schneider Stéphane M
Department of Clinical Medicine, Sapienza- University of Rome, Viale dell'Università, 37, 00185 Roma, Italy.
Department of Gastroenterology and Centre for Clinical Nutrition, Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
Clin Nutr. 2017 Aug;36(4):939-957. doi: 10.1016/j.clnu.2016.06.022. Epub 2016 Jul 12.
BACKGROUND & AIMS: Disease-related malnutrition has deleterious consequences on patients' outcome and healthcare costs. The demonstration of improved outcome by appropriate nutritional management is on occasion difficult. The European Society of Clinical Nutrition and Metabolism (ESPEN) appointed the Nutrition Education Study Group (ESPEN-NESG) to increase recognition of nutritional knowledge and support in health services.
To obtain the best available evidence on the potential effects of malnutrition on morbidity, mortality and hospital stay; cost of malnutrition; effect of nutritional treatment on outcome parameters and pharmaco-economics of nutritional therapy, a systematic review of the literature was performed following Cochrane methodology, to answer the following key questions: Q1) Is malnutrition an independent predictive factor for readmission within 30 days from hospital discharge? Q2) Does nutritional therapy reduce the risk of readmission within 30 days from hospital discharge? Q3) Is nutritional therapy cost-effective/does it reduce costs in hospitalized patients? and Q4) Is nutritional therapy cost effective/does it reduce costs in outpatients?
For Q1 six of 15 identified observational studies indicated that malnutrition was predictive of re-admissions, whereas the remainder did not. For Q2 nine randomized controlled trials and two meta-analyses gave non-conclusive results whether re-admissions could be reduced by nutritional therapy. Economic benefit and cost-effectiveness of nutritional therapy was consistently reported in 16 identified studies for hospitalized patients (Q3), whereas the heterogeneous and limited corresponding data on out-patients (Q4) indicated cost-benefits in some selected sub-groups.
This result of this review supports the use of nutritional therapy to reduce healthcare costs, most evident from large, homogeneous studies. In general, reports are too heterogeneous and overall of limited quality for conclusions on impact of malnutrition and its treatment on readmissions.
疾病相关的营养不良会对患者的预后和医疗成本产生有害影响。通过适当的营养管理来证明改善预后有时很困难。欧洲临床营养与代谢学会(ESPEN)任命了营养教育研究小组(ESPEN-NESG),以提高对营养知识的认识并在卫生服务中提供支持。
为了获得关于营养不良对发病率、死亡率和住院时间的潜在影响;营养不良的成本;营养治疗对预后参数的影响以及营养治疗的药物经济学的最佳现有证据,按照Cochrane方法对文献进行了系统综述,以回答以下关键问题:问题1)营养不良是否是出院后30天内再次入院的独立预测因素?问题2)营养治疗是否能降低出院后30天内再次入院的风险?问题3)营养治疗在住院患者中是否具有成本效益/是否能降低成本?以及问题4)营养治疗在门诊患者中是否具有成本效益/是否能降低成本?
对于问题1,15项已确定的观察性研究中有6项表明营养不良可预测再次入院,而其余研究则未表明。对于问题2,9项随机对照试验和2项荟萃分析对于营养治疗是否能降低再次入院率给出了不确定的结果。在16项已确定的针对住院患者的研究中一致报告了营养治疗的经济效益和成本效益(问题3),而关于门诊患者的异质性且有限的相应数据(问题4)表明在一些选定的亚组中有成本效益。
本综述的结果支持使用营养治疗来降低医疗成本,这在大型、同质的研究中最为明显。总体而言,报告过于异质性且质量有限,无法就营养不良及其治疗对再次入院的影响得出结论。